Ilsung Is Co., Ltd. (KRX: 003120)

South Korea flag South Korea · Delayed Price · Currency is KRW
15,960
-40 (-0.25%)
Dec 20, 2024, 3:30 PM KST
-36.16%
Market Cap 111.23B
Revenue (ttm) 74.17B
Net Income (ttm) -11.78B
Shares Out 6.97M
EPS (ttm) -1,735.65
PE Ratio n/a
Forward PE n/a
Dividend 1,500.00 (9.40%)
Ex-Dividend Date Dec 27, 2024
Volume 4,683
Open 15,910
Previous Close 16,000
Day's Range 15,800 - 16,030
52-Week Range 15,200 - 27,550
Beta -0.24
Analysts n/a
Price Target n/a
Earnings Date Feb 25, 2025

About Ilsung Is

Ilsung Is Co., Ltd. operates as a pharmaceutical company in South Korea. Its products include antibiotics, analgesics, muscle relaxants, antipyretic-analgesics, antihistamine, neuropsychiatric, neuromuscular blocker/ central muscle relaxants, anti-coagulants, probiotics, vaccine, medical equipment, circulatory system drugs, contrast agents, muscle relaxants, diabetes treatments, osteopathic, digestive system medicines, anti-virals, anti-emetics, respiratory treatments, adrenal cortical steroids, anesthetics, antipyretics, and cardiovascular sys... [Read more]

Sector Healthcare
Founded 1954
Country South Korea
Stock Exchange Korea Stock Exchange
Ticker Symbol 003120
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.